Ophthalmic viscoelastic compositions
US-2024066181-A1 · Feb 29, 2024 · US
US9757499B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9757499-B2 |
| Application number | US-201414569199-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2014 |
| Priority date | Jun 12, 2012 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Biofunctional films and methods of use thereof for the prevention of post-operative adhesions are disclosed.
Opening claim text (preview).
What is claimed is: 1. A method of preventing post-surgical adhesions in a patient in need thereof comprising: providing a complex of polyeletrolytes (PEC), comprising a mixture of polycationic chitosan and polyanionic polygalacturonic acid (PGA) in the form of a dry film; introducing said dry film into a surgical site, said dry film being effective to separate healing tissues, and maintaining said dry film post-operatively at said surgical site for a period of at least seven days. 2. The method of claim 1 , wherein said dry film comprises a mixture of chitosan and polygalacturonic acid in a ratio of 1:1 by weight, or a ratio in which the weight percent of polyanionic PGA exceeds the weight percent of polycationic chitosan in said dry film, thereby imparting an overall negative charge to said film. 3. The method of claim 2 , wherein said dry film comprises a mixture of chitosan and polygalacturonic acids in a ratio of 40:60 by weight. 4. The method of claim 3 wherein said dry film has a thickness between 75-250 microns. 5. The method of claim 4 , wherein said dry film has a thickness of about 100 microns. 6. The method of claim 4 , wherein said dry film has a thickness of about 180 microns. 7. The method of claim 1 , wherein said complex of polyeletrolytes exhibits anti-inflammatory properties. 8. The method of claim 1 , wherein the surgical site is produced from cardiosurgery, articular surgery, abdominal surgery, thoracic surgery, surgery in the urogenital region, nerve surgery, tendon surgery, laparascopic surgery, pelvic surgery, oncological surgery, sinus and craniofacial surgery, ENT surgery, ophthalmological surgery, or a procedure involving spinal dura repair. 9. The method of claim 1 , wherein the dry film is preformed prior to contacting the surgical site. 10. The method of claim 2 , wherein said complex of polyeletrolytes further comprises pectin or dextran sulphate. 11. The method of claim 10 , wherein said complex of polyeletrolytes comprises chitosan-polygalacturonic acid-pectin. 12. The method of claim 11 , wherein said complex of polyeletrolytes comprises about 40% chitosan, about 55% polygalacturonic acid and about 5% pectin. 13. The method of claim 10 , wherein said complex of polyeletrolytes comprises chitosan-galacturonic acid-dextran sulphate. 14. The method of claim 13 , wherein said complex of polyeletrolytes comprises about 40% chitosan, about 40% galacturonic acid and about 20% dextran sulphate. 15. A method of preventing post-surgical adhesions in a patient in need thereof comprising: providing a complex of polyeletrolytes (PEC), comprising a mixture of polycationic chitosan and polyanionic polygalacturonic acid (PGA); introducing said mixture into said surgical, said mixture forming a film at said site, said film being effective to separate healing tissues, and maintaining said film post-operatively at said surgical site for a period of at least seven days.
Polysaccharides · CPC title
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00 · CPC title
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
Manufacture of films or sheets · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.